Literature DB >> 26296046

Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm.

Alfonso Rubio-Navarro1, Juan Manuel Amaro Villalobos1, Jes S Lindholt2, Irene Buendía1, Jesús Egido3, Luis Miguel Blanco-Colio1, Rafael Samaniego4, Olivier Meilhac5, Jean Baptiste Michel6, José Luis Martín-Ventura1, Juan Antonio Moreno7.   

Abstract

BACKGROUND: Increased hemoglobin (Hb) accumulation was reported in abdominal aortic aneurysms (AAAs). CD163 is a macrophage receptor involved in tissue Hb clearance, however its role in AAA has not been reported. We investigated the role of Hb on monocyte recruitment and differentiation towards CD163 expressing macrophages ex vivo, in vitro and in human AAA. METHODS AND
RESULTS: CD163 mRNA and protein expression was significantly higher in human AAA (n=7) vs. healthy wall (n=6). CD163 was predominantly found in adventitia of AAA, coinciding with areas rich in hemosiderin and adjacent to neoangiogenic microvessels. Dual CD14/CD163 expression was observed in recently infiltrated monocytes surrounding microvessels. A higher release of soluble CD163 was observed in the conditioned medium from AAA (AAA-CM, n=10), mainly in the adventitial layer. Similar to Hb, AAA-CM induced CD163-dependent monocyte chemotaxis, especially on circulating monocytes from AAA patients. Hb or AAA-CM promoted differentiation towards CD163(high)/HLA-DR(low)-expressing macrophages, with enhanced Hb uptake, increased anti-inflammatory IL-10 secretion and decreased pro-inflammatory IL-12p40 release. All these effects were partially suppressed when Hb was removed from AAA-CM. Separate analysis on circulating monocytes reported increased percentage of pre-infiltrating CD14(++)CD16(+) monocytes in patients with AAA (n=21), as compared to controls (n=14). A significant increase in CD163 expression in CD14(++)CD16(+) monocyte subpopulation was observed in AAA patients.
CONCLUSIONS: The presence of Hb in the adventitial AAA-wall promotes the migration and differentiation of activated circulating monocytes in AAA patients, explaining the existence of a protective CD163-macrophage phenotype that could take up the Hb present in the AAA-wall, avoiding its injurious effects.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic abdominal aneurysm; CD163; Hemoglobin; Macrophages

Mesh:

Substances:

Year:  2015        PMID: 26296046     DOI: 10.1016/j.ijcard.2015.08.053

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Monocytes and macrophages in abdominal aortic aneurysm.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2017-04-13       Impact factor: 32.419

2.  A Subpopulation of Monocytes in Normal Human Blood Has Significant Magnetic Susceptibility: Quantification and Potential Implications.

Authors:  James Kim; Jenifer Gómez-Pastora; Mitchell Weigand; Marnie Potgieter; Nicole A Walters; Eduardo Reátegui; Andre F Palmer; Mark Yazer; Maciej Zborowski; Jeffrey J Chalmers
Journal:  Cytometry A       Date:  2019-04-08       Impact factor: 4.355

Review 3.  Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores.

Authors:  Franziska Roth-Walter
Journal:  Front Allergy       Date:  2022-05-10

Review 4.  Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors.

Authors:  Rodrigo Barbosa de Aguiar; Jane Zveiter de Moraes
Journal:  Front Immunol       Date:  2019-05-09       Impact factor: 7.561

5.  Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway.

Authors:  Xian-Qiang Ni; Ya-Rong Zhang; Li-Xin Jia; Wei-Wei Lu; Qing Zhu; Jin-Ling Ren; Yao Chen; Lin-Shuang Zhang; Xin Liu; Yan-Rong Yu; Mo-Zhi Jia; Zhong-Ping Ning; Jie Du; Chao-Shu Tang; Yong-Fen Qi
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.